CME Launches AVAX and SUI Futures, Expanding Crypto Derivatives Offerings

iconCryptofrontnews
Share
AI summary iconSummary
CME launched AVAX and SUI futures, adding to its regulated crypto derivatives lineup. The contracts come in standard and micro sizes, offering better capital efficiency. AVAX and SUI show distinct correlations with major cryptos, reflecting varied trading patterns. This move brings more options for traders in crypto news. With more altcoins entering futures markets, crypto today is seeing broader institutional access.
  • CME introduced Avalanche and Sui futures, expanding regulated crypto derivatives beyond Bitcoin, Ether, and major altcoins.
  • Contracts include standard and micro sizes, enabling capital-efficient trading and strategies like spreads and arbitrage.
  • AVAX and SUI show differing correlations and volatility, highlighting growing focus on protocol-specific trading behavior.

Crypto derivatives trading widened further this week after CME introduced Avalanche and Sui futures contracts for institutional and retail participants. The launch adds AVAX, Micro AVAX, SUI, and Micro SUI futures to CME’s cryptocurrency suite, following February’s rollout of Cardano, Chainlink, and Stellar futures. The contracts are cash-settled using CME CF Reference Rates and target growing demand for regulated Layer-1 trading exposure.

New Contracts Expand Crypto Access

CME said the contracts offer exposure beyond Bitcoin and Ether while improving capital efficiency for traders. Notably, the futures allow potential margin offsets when traded alongside existing crypto products.

The exchange introduced both standard and Micro-sized contracts to serve different trading strategies and portfolio sizes. According to CME, the products support investors seeking exposure to high-throughput blockchain networks without holding spot assets directly.

The launch also follows continued growth across CME’s cryptocurrency segment. During the first quarter of 2026, average daily open interest reached 313,900 contracts. That figure marked a 25% increase from the same period in 2025.

As activity expanded, traders also incorporated recently launched Cardano, Chainlink, and Stellar futures into portfolio management strategies.

Traders Focus on Relative-Value Strategies

CME said Avalanche and Sui futures could support several trading approaches, including relative-value and inter-commodity spreads. Traders may position AVAX or SUI against assets such as Solana, Bitcoin, or Ether.

EliteFXLabs Banner

The exchange also highlighted arbitrage and basis trading opportunities tied to the futures curve and spot market pricing. Because the contracts settle against CME CF Reference Rates, the exchange said they may improve pricing transparency across crypto markets.

Meanwhile, CME data showed AVAX maintains a 0.70 correlation with Bitcoin, while SUI records a 0.61 correlation. AVAX also showed strong correlation with Solana and Cardano at 0.75.

However, SUI displayed lower correlations with payment-focused assets including XRP and Stellar Lumens.

Risk Profiles Differ Across Assets

CME’s analysis showed Avalanche carried the highest annualized risk among the compared assets. However, historical returns remained more moderate than several competing cryptocurrencies.

SUI, meanwhile, showed high volatility alongside negative historical returns due to its shorter market history and recent emergence.

The exchange added that traders increasingly separate assets based on protocol-specific characteristics rather than broader crypto market direction.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.